Evidence mapPaperPMID 34201756Full record

ReviewInternational journal of molecular sciences2021

The Role of Mitochondrial Mutations and Chronic Inflammation in Diabetes.

Siarhei A Dabravolski, Varvara A Orekhova, Mirza S Baig, Evgeny E Bezsonov, Antonina V Starodubova, Tatyana V Popkova, Alexander N Orekhov

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Albumin-corrected anion gap and risk of mortality among US adults.Archives of public health = Archives belges de sante publique · 2025
    Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Mitochondrial Dysfunction in Diabetes: Shedding Light on a Widespread Oversight.Pathophysiology : the official journal of the International Society for Pathophysiology · 2025
    Review
  11. The Putative Antidiabetic Effect ofInternational journal of molecular sciences · 2025
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Siarhei A DabravolskiDepartment of Clinical Diagnostics, Vitebsk State Academy of Veterinary Medicine, 210026 Vitebsk, Belarus.
Varvara A OrekhovaLaboratory of Angiopathology, Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia.
Mirza S BaigDepartment of Biosciences and Biomedical Engineering (BSBE), Indian Institute of Technology Indore (IITI), Simrol 456552, India.
Evgeny E BezsonovLaboratory of Angiopathology, Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia.ORCID 0000-0002-9382-8338
Antonina V StarodubovaFederal Research Centre for Nutrition, Biotechnology and Food Safety, 109240 Moscow, Russia.ORCID 0000-0001-9262-9233
Tatyana V PopkovaV.A. Nasonova Institute of Rheumatology, 115522 Moscow, Russia.
Alexander N OrekhovLaboratory of Angiopathology, Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia.ORCID 0000-0002-3318-4681
Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences · RUAssociation of Rheumatologists of Russia · RUFederal Research Centre of Nutrition and Biotechnology · RUIndian Institute of Technology Indore · INVitebsk State Academy of Veterinary Medicine · BY

Funding

Russian Science Foundation 18-15-00254
6 · The paper itself

Abstract

Diabetes mellitus and related disorders significantly contribute to morbidity and mortality worldwide. Despite the advances in the current therapeutic methods, further development of anti-diabetic therapies is necessary. Mitochondrial dysfunction is known to be implicated in diabetes development. Moreover, specific types of mitochondrial diabetes have been discovered, such as MIDD (maternally inherited diabetes and deafness) and DAD (diabetes and Deafness). Hereditary mitochondrial disorders are caused by certain mutations in the mitochondrial DNA (mtDNA), which encodes for a substantial part of mitochondrial proteins and mitochondrial tRNA necessary for mitochondrial protein synthesis. Study of mtDNA mutations is challenging because the pathogenic phenotype associated with such mutations depends on the level of its heteroplasmy (proportion of mtDNA copies carrying the mutation) and can be tissue-specific. Nevertheless, modern sequencing methods have allowed describing and characterizing a number of mtDNA mutations associated with human disorders, and the list is constantly growing. In this review, we provide a list of mtDNA mutations associated with diabetes and related disorders and discuss the mechanisms of their involvement in the pathology development.

Indexed as

MutationAnimalsChronic DiseaseDeafnessDiabetes MellitusDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2DNA, MitochondrialFemaleGenome, MitochondrialHumansInflammationMiceMitochondrial DiseasesDNA, MitochondrialdiabetesMIDDmitochondriamtDNA mutationsoxidative stress

Identifiers

PMID34201756
PMCPMC8268113
OpenAlexW3176329657

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.